MiR-507 inhibits the progression of gastric carcinoma via targeting CBX4-mediated activation of Wnt/β-catenin and HIF-1α pathways - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/35819589/
doi: 10.1007/s12094-022-02862-3. Online ahead of print. 1 Department of Medical Oncology, Hangzhou Cancer Hospital, 34 Yanguan Lane, Shangcheng District, Hangzhou, 310000, Zhejiang, China. 2 Department of Medical Oncology, Hangzhou Cancer Hospital, 34 Yanguan Lane, Shangcheng District, Hangzhou, 310000, Zhejiang, China. [email protected]. doi: 10.1007/s12094-022-02862-3. Online ahead of print.
Conclusions: In conclusion, it suggests that miR-507 could inhibit the progression of GC via regulating CBX4-mediated activation of Wnt/β-catenin and HIF-1α pathways.